Efficacy and safety of GLP ‐1 receptor agonists and SGLT2 inhibitors as adjuncts to insulin in type 1 diabetes: Systematic review and meta‐analysis

Documenti analoghi

• Safety of GLP ‐1 and Dual GLP ‐1/ GIP Receptor Agonists in Preconception, Pregnancy, and Lactation: A Systematic Review of Maternal, Fetal, and Neonatal Outcomes
  di: Lasin Ozbek, et al.
  Pubblicazione: (2026)
• The Exposome Era in Kidney Transplantation: A New Frontier in Graft Outcomes and Precision Medicine
  di: Mustafa Guldan, et al.
  Pubblicazione: (2025)
• Glucagon and glucagon‐like peptide‐1 dual agonist therapy: A possible future towards fatty kidney disease
  di: Mehmet Kanbay, et al.
  Pubblicazione: (2024)
• The Impact of Ultra‐Processed Food Consumption on Frailty and Sarcopenia: A Systematic Review
  di: Mehmet Kanbay, et al.
  Pubblicazione: (2025)
• Nutrition, cognition and chronic kidney disease: A comprehensive review of interactions and interventions
  di: Mehmet Kanbay, et al.
  Pubblicazione: (2025)